The INVOcell story
INVO Bioscience is dedicated to making fertility care accessible and inclusive to people around the world. Our flagship product is INVOcell, a revolutionary reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.
The INVOcell story began when an embryologist at the fertility clinic at Cochin Hospital at Paris Descartes University, discovered that embryos could be preserved in the woman’s body, which acts as a natural incubator.
When the power went out in the lab, the embryologist had to act quickly to preserve the eggs and sperm he was working with. He loaded fertilized eggs into sealed vials and asked the women if they would hold the vials inside of their bodies to keep them warm. Patients obliged, and their bodies’ natural warmth replicated what had been happening in the lab for years.
INVOcell was patented and FDA cleared in 2016, received CE mark in 2019 and is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. It is the only alternative to traditional in vitro fertilization with nearly the same results.
For millions struggling with infertility, access to treatment is often not possible. Financial challenges, limited availability of specialized medical care, and social or cultural roadblocks can prevent these hopeful parents from realizing their dream to have a baby. INVOcell provides a solution that gives patients access to a safe, effective and more affordable fertility treatment.